Cargando…

Clinical Features and Treatment of Ocular Toxoplasmosis

Ocular toxoplasmosis is a disease caused by the infection with Toxoplasma gondii through congenital or acquired routes. Once the parasite reaches the retina, it proliferates within host cells followed by rupture of the host cells and invasion into neighboring cells to make primary lesions. Sometimes...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Young-Hoon, Nam, Ho-Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Parasitology and Tropical Medicine 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770869/
https://www.ncbi.nlm.nih.gov/pubmed/24039281
http://dx.doi.org/10.3347/kjp.2013.51.4.393
_version_ 1782284148920025088
author Park, Young-Hoon
Nam, Ho-Woo
author_facet Park, Young-Hoon
Nam, Ho-Woo
author_sort Park, Young-Hoon
collection PubMed
description Ocular toxoplasmosis is a disease caused by the infection with Toxoplasma gondii through congenital or acquired routes. Once the parasite reaches the retina, it proliferates within host cells followed by rupture of the host cells and invasion into neighboring cells to make primary lesions. Sometimes the restricted parasite by the host immunity in the first scar is activated to infect another lesion nearby the scar. Blurred vision is the main complaint of ocular toxoplasmic patients and can be diagnosed by detection of antibodies or parasite DNA. Ocular toxoplasmosis needs therapy with several combinations of drugs to eliminate the parasite and accompanying inflammation; if not treated it sometimes leads to loss of vision. We describe here clinical features and currently available chemotherapy of ocular toxoplasmosis.
format Online
Article
Text
id pubmed-3770869
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher The Korean Society for Parasitology and Tropical Medicine
record_format MEDLINE/PubMed
spelling pubmed-37708692013-09-13 Clinical Features and Treatment of Ocular Toxoplasmosis Park, Young-Hoon Nam, Ho-Woo Korean J Parasitol Mini-Review Ocular toxoplasmosis is a disease caused by the infection with Toxoplasma gondii through congenital or acquired routes. Once the parasite reaches the retina, it proliferates within host cells followed by rupture of the host cells and invasion into neighboring cells to make primary lesions. Sometimes the restricted parasite by the host immunity in the first scar is activated to infect another lesion nearby the scar. Blurred vision is the main complaint of ocular toxoplasmic patients and can be diagnosed by detection of antibodies or parasite DNA. Ocular toxoplasmosis needs therapy with several combinations of drugs to eliminate the parasite and accompanying inflammation; if not treated it sometimes leads to loss of vision. We describe here clinical features and currently available chemotherapy of ocular toxoplasmosis. The Korean Society for Parasitology and Tropical Medicine 2013-08 2013-08-30 /pmc/articles/PMC3770869/ /pubmed/24039281 http://dx.doi.org/10.3347/kjp.2013.51.4.393 Text en © 2013, Korean Society for Parasitology and Tropical Medicine http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Mini-Review
Park, Young-Hoon
Nam, Ho-Woo
Clinical Features and Treatment of Ocular Toxoplasmosis
title Clinical Features and Treatment of Ocular Toxoplasmosis
title_full Clinical Features and Treatment of Ocular Toxoplasmosis
title_fullStr Clinical Features and Treatment of Ocular Toxoplasmosis
title_full_unstemmed Clinical Features and Treatment of Ocular Toxoplasmosis
title_short Clinical Features and Treatment of Ocular Toxoplasmosis
title_sort clinical features and treatment of ocular toxoplasmosis
topic Mini-Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770869/
https://www.ncbi.nlm.nih.gov/pubmed/24039281
http://dx.doi.org/10.3347/kjp.2013.51.4.393
work_keys_str_mv AT parkyounghoon clinicalfeaturesandtreatmentofoculartoxoplasmosis
AT namhowoo clinicalfeaturesandtreatmentofoculartoxoplasmosis